Cited by 31Gene expression and cancer classificationDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Deep belief network-based approach for detecting Alzheimer's disease using the multi-omics data

Open access
Mahendran, Nivedhitha, Vincent P M, Durai Raj·2023·Computational and Structural Biotechnology Journal

Abstract

Alzheimer's disease (AD) is the most uncertain form of Dementia in terms of finding out the mechanism. AD does not have a vital genetic factor to relate to. There were no reliable techniques and methods to identify the genetic risk factors associated with AD in the past. Most of the data available were from the brain images. However, recently, there have been drastic advancements in the high-throughput techniques in bioinformatics. It has led to focused researches in discovering the AD causing genetic risk factors. Recent analysis has resulted in considerable prefrontal cortex data with which classification and prediction models can be developed for AD. We have developed a Deep Belief Network-based prediction model using the DNA Methylation and Gene Expression Microarray Data, with High Dimension Low Sample Size (HDLSS) issues. To overcome the HDLSS challenge, we performed a two-layer feature selection considering the biological aspects of the features as well. In the two-layered feature selection approach, first the differentially expressed genes and differentially methylated positions are identified, then both the datasets are combined using Jaccard similarity measure. As the second step, an ensemble-based feature selection approach is implemented to further narrow down the gene selection. The results show that the proposed feature selection technique outperforms the existing commonly used feature selection techniques, such as Support Vector Machine Recursive Feature Elimination (SVM-RFE), and Correlation-based Feature Selection (CBS). Furthermore, the Deep Belief Network-based prediction model performs better than the widely used Machine Learning models. Also, the multi-omics dataset shows promising results compared to the single omics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.csbj.2023.02.021

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DBNs have proven effective in addressing the high-dimensional, low-sample-size challenge inherent to multi-omics datasets, demonstrating superior performance in feature selection and classification compared to conventional methods such as SVM-RFE.

    “DBNs have also proven effective in addressing the high-dimensional, low-sample-size challenge inherent to multi-omics datasets, demonstrating superior performance in feature selection and classification compared to conventional methods such as SVM-RFE237.”

    From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [237]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • DBNs integrate gene expression and methylation features to improve classification accuracy, while E-VAEs reveal interpretable genomic-transcriptomic interactions linked to AD pathways.

    “Deep Belief Networks (DBNs) integrate gene expression and methylation features to improve classification accuracy, while Explainable Variational Autoencoders (E-VAEs) reveal interpretable genomic-transcriptomic interactions linked to AD pathways237,285.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 43 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Mahendran, N., & Vincent P M, D. R.
Affiliations
  • Vellore Institute of Technology University (IN)
  • School of Information Technology and Engineering, Vellore Institute of Technology, Vellore, India
Corresponding author
Mahendran, Nivedhitha
Venue
Computational and Structural Biotechnology Journal
Published
2023-01
Volume
21
Pages
1651-1660
ISSN
2001-0370 (ISSN-L)
OpenAlex
W4320487111
Cited by
31
References
43
Citations by year
2026: 7 · 2025: 9 · 2024: 12 · 2023: 3
FWCI
2.76
Type
journal article
Language
en
Open access
Locations
  • Computational and Structural Biotechnology Journal (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, deep belief network, multi-omics data, DNA methylation, gene expression microarrays, high-dimensional small-sample data, feature selection, Jaccard similarity, ensemble feature selection, differentially methylated positions, differentially expressed genes, prefrontal cortex, Alzheimer's disease prediction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review